Wird geladen...

Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance)

PURPOSE: Skeletal-related events (SREs) such as pathologic fracture, spinal cord compression, or the necessity for radiation or surgery to bone metastasis cause considerable morbidity, decrements in quality of life, and costs to the health care system. The results of a recent large randomized trial...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Oncol
Hauptverfasser: Shapiro, Charles L., Moriarty, James P., Dusetzina, Stacie, Himelstein, Andrew L., Foster, Jared C., Grubbs, Stephen S., Novotny, Paul J., Borah, Bijan J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2017
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721226/
https://ncbi.nlm.nih.gov/pubmed/29023215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.73.7437
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!